Aeolus Pharmaceuticals, Inc.
AOLSOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$15209
P/E Ratio—
52W High$0.0001
52W Low$0.0001
Aeolus Pharmaceuticals, Inc. (AOLS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AOLS · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2017Report Date: Aug 14, 2017EPS Actual
-$0.01
Revenue
$0.00B
Fiscal Period
Q3 FY2017
FY ends December
Report Date
Aug 14, 2017
After Market Close
AOLS reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $6.21B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$6.21B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q3 FY2017 | Aug 14, 2017 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2017 | May 15, 2017 | — | -$0.01 | — | $0.00B | — | — |
| — Q1 FY2017 | Feb 17, 2017 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2016 | Dec 21, 2016 | — | -$0.01 | — | $0.00B | — | — |
| — Q3 FY2016 | Aug 15, 2016 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2016 | May 16, 2016 | — | -$0.02 | — | $0.00B | — | — |
| — Q1 FY2016 | Feb 16, 2016 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2015 | Dec 18, 2015 | — | -$0.00 | — | $0.00B | — | — |
Q3 FY2017
Aug 14, 2017
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2017
May 15, 2017
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2017
Feb 17, 2017
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2016
Dec 21, 2016
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2016
Aug 15, 2016
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2016
May 16, 2016
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2016
Feb 16, 2016
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2015
Dec 18, 2015
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for AOLS.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2017 | Aug 14, 2017 | — | $0.08 | $0.08 | -4.16% |
| — Q2 FY2017 | May 15, 2017 | — | $0.10 | $0.10 | -4.00% |
| — Q1 FY2017 | Feb 17, 2017 | — | $0.19 | $0.20 | +1.03% |
| — Q4 FY2016 | Dec 21, 2016 | — | $0.18 | $0.18 | +1.12% |
| — Q3 FY2016 | Aug 15, 2016 | — | $0.25 | $0.25 | +0.00% |
| — Q2 FY2016 | May 16, 2016 | — | $0.17 | $0.17 | +3.03% |
| — Q1 FY2016 | Feb 16, 2016 | — | $0.20 | $0.20 | +0.10% |
| — Q4 FY2015 | Dec 18, 2015 | — | $0.22 | $0.22 | +0.00% |
Q3 FY2017-4.16%
Report Date
Aug 14, 2017
EPS Beat/Miss
—
Price Before
$0.08
Price After
$0.08
Q2 FY2017-4.00%
Report Date
May 15, 2017
EPS Beat/Miss
—
Price Before
$0.10
Price After
$0.10
Q1 FY2017+1.03%
Report Date
Feb 17, 2017
EPS Beat/Miss
—
Price Before
$0.19
Price After
$0.20
Q4 FY2016+1.12%
Report Date
Dec 21, 2016
EPS Beat/Miss
—
Price Before
$0.18
Price After
$0.18
Q3 FY2016+0.00%
Report Date
Aug 15, 2016
EPS Beat/Miss
—
Price Before
$0.25
Price After
$0.25
Q2 FY2016+3.03%
Report Date
May 16, 2016
EPS Beat/Miss
—
Price Before
$0.17
Price After
$0.17
Q1 FY2016+0.10%
Report Date
Feb 16, 2016
EPS Beat/Miss
—
Price Before
$0.20
Price After
$0.20
Q4 FY2015+0.00%
Report Date
Dec 18, 2015
EPS Beat/Miss
—
Price Before
$0.22
Price After
$0.22
Beat Rate0 / 8 quarters
Largest Move-4.16% (Q3 FY2017)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AOLS ends December
Aeolus Pharmaceuticals, Inc. (AOLS) most recently reported earnings on August 14, 2017 for Q3 FY2017, posting EPS of $-0.01 (in line with the analyst consensus of —). The next AOLS earnings date is expected around September 1, 2026.
Each quarter, investors track AOLS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AOLS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AOLS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AOLS earnings · 4 questionsAeolus Pharmaceuticals, Inc.'s next earnings report is expected around September 1, 2026. AOLS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AOLS historically reports after market close (AMC).
AOLS earnings datewhen is AOLS earningsAOLS next earnings datewhen does AOLS report earningsAOLS earnings calendar
▸ Source: FMP · Aeolus Pharmaceuticals, Inc. SEC filings · US GAAP · Aeolus Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026